PRNHX (PRNHX) Stock Price & Analysis
PRNHX (PRNHX) fell 0.05% to USD 56.98 as of June 10, 2026 at 11:02 UTC, according to Nexqual real-time market data.
PRNHX last closed at USD 57.01; the session ranged USD 56.98–56.98 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.95–59.63 (NAS). Source: Nexqual, June 10, 2026 at 11:02 UTC.
Key Statistics (as of June 10, 2026 at 11:02 UTC)
| Price | USD 56.98 |
|---|---|
| Change | ▼ 0.05% (down) |
| Previous Close | USD 57.01 |
| Open | USD 56.98 |
| Day Range | USD 56.98 – 56.98 |
| 52-Week Range | USD 48.95 – 59.63 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRNHX)
Nexqual's technical model rates PRNHX "NEUTRAL" based on 3 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 11:02 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.82 (neutral) |
| vs SMA50 | Above (USD 56.03) |
| MACD | 0.53 (positive) |
Financial Health Score (PRNHX)
Nexqual rates PRNHX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 11:02 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRHSX | T. Rowe Price Health Sciences F | USD 82.82 | ▲ 1.4% |
| RPMGX | T. Rowe Price Mid-Cap Growth Fu | USD 98.74 | ▲ 0.96% |
| PRFDX | T. Rowe Price Equity Income Fd | USD 43.05 | ▲ 0.63% |
| PRSCX | T. Rowe Price Science and Techn | USD 73.91 | ▲ 1.36% |
| PRGFX | T. Rowe Price Growth Stock Fd | USD 109.49 | ▼ 0.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 11:02 UTC. This page is informational and not investment advice.